Sanyou Bio conducted a full review of its Intelligent Super-trillion Molecule Discovery Platform. As the core technology of the platform, the intelligent super-trillion molecule library boasts a ...

When Cathy Tie started Locke Bio, a Culver City-based digital health startup, she had spent years as a venture capitalist ...

Bio-Rad Laboratories, Inc. BIO recently entered into a binding agreement to purchase all equity interests in Stilla Technologies ("Stilla"). Stilla’s next-generation digital PCR solutions complement ...

Systemic Bio™, a subsidiary of 3D Systems, has won the SLAS 2025 Innovation Award for its h-VIOS™ platform, which enhances drug discovery by using bioprinted human tissues to evaluate antibody ...

A2 Bio plans to direct the Series C funds to support the company’s three clinical studies, as well as to advance preclinical programs using its Tmod™ platform for potential clinical targets ...

To address those issues, Trenchant is developing a fully-automated cell therapy manufacturing platform for CAR-T cells. It recently partnered with Autolomous, integrating its digital solution into ...

Bio-Hermes-002 is the unique, observational platform study that compares blood-based and digital biomarkers across a broad range of clinical cognitive conditions, MRI and PET images as well as ...